Jubilant Pharmova Ltd.
BSE: 530019 | Sector: Health care |
NSE: JUBLPHARMA | ISIN Code: INE700A01033 |
BSE 00:00 | 27 Jan | 338.10 |
-8.25 (-2.38%) |
OPEN
347.15 |
HIGH
349.50 |
LOW
329.40 |
NSE 00:00 | 27 Jan | 337.65 |
-9.00 (-2.60%) |
OPEN
345.00 |
HIGH
350.05 |
LOW
331.05 |
OPEN | 347.15 |
PREVIOUS CLOSE | 346.35 |
VOLUME | 12565 |
52-Week high | 555.00 |
52-Week low | 305.20 |
P/E | 58.70 |
Mkt Cap.(Rs cr) | 5,386 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Jubilant Pharmova Ltd. (JUBLPHARMA) - Half Yearly Result
Particulars (![]() |
Sep '22 | Mar '22 | Sep '21 | Mar '21 | Sep '20 |
Net Sales/Income From Operations | 427.54 | 396.16 | 329.57 | 1194.80 | 1514.70 |
Other Income | 116.36 | 15.76 | 110.40 | 26.01 | 21.87 |
Total Income | 543.90 | 411.92 | 439.97 | 1220.81 | 1536.57 |
Total Expenditure | 424.61 | 393.68 | 325.59 | 1018.23 | 1264.21 |
Operating Profit | 119.29 | 18.24 | 114.38 | 202.58 | 272.36 |
Interest | 7.29 | 5.66 | 5.33 | 34.87 | 66.93 |
Gross Profit | 112.00 | 12.58 | 109.05 | 167.71 | 205.43 |
Depreciation | 20.29 | 18.49 | 18.42 | 40.85 | 59.12 |
PBT | 91.71 | -5.91 | 90.63 | 126.86 | 146.31 |
Tax | 14.40 | -1.86 | 16.14 | 27.05 | 25.42 |
Net Profit/(Loss) | 86.63 | -5.14 | 85.63 | 99.81 | 114.67 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 86.63 | -5.14 | 85.63 | 99.81 | 114.67 |
Equity Share Capital | 15.93 | 15.93 | 15.93 | 15.93 | 15.93 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 2705.05 |
EPS | |||||
Basic EPS | 5.44 | 0.00 | 5.37 | 6.27 | 7.20 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Jubilant Pharmova:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices